Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3. - Liu, Chang; Wang, Xin; Xu, Chao; Liu, Xiaoxiang; Ke, Liyan; Li, Ying; Zhang, Hang; Tan, Jianqiang; Tan, Senwei; Zhang, Zitong; Cheng, Liang; Ren, Yaqiong; et al. (BMC Neurology, 2025)